Lynparza (olaparib) - Merck (MSD), AstraZeneca
ARN-3236 - Arrien
http://www.abstractsonline.com/pp8/#!/4562/presentation/6315
 
Zhen Lu1, Wequn Mao1, Lan Pang1, Janice M. Santiago-O'Farrill1, Haling Yang1, Ahmed Ahmed2, Hariprasad Vankayalapati3, Robert C. Bast1. 1UT MD Anderson Cancer Center, Houston, TX; 2Oxford University, Oxford, United Kingdom; 3Arrien Pharmaceuticals, Salt Lake City, UT
 
Mar 16, 2018
 
Prev Next